1. Home
  2. PLSE

as of 01-06-2026 3:43pm EST

$14.81
+$0.21
+1.40%
Stocks Health Care Medical/Dental Instruments Nasdaq

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Founded: 2014 Country:
United States
United States
Employees: N/A City: HAYWARD
Market Cap: 1.2B IPO Year: 2016
Target Price: $22.00 AVG Volume (30 days): 193.9K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.13 EPS Growth: N/A
52 Week Low/High: $12.56 - $25.00 Next Earning Date: 11-05-2025
Revenue: $86,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 1002.94%

AI-Powered PLSE Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.50%
75.50%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: